The $8.5 million difference
The $8.5 million difference
Less than two years after telling start-up GeneSys Therapeutics Corp. that it should seek a merger partner because of a glut of gene therapy companies, Kleiner Perkins Caufield & Byers
Gathering data...
Less than two years after telling start-up GeneSys Therapeutics Corp. that it should seek a merger partner because of a glut of gene therapy companies, Kleiner Perkins Caufield & Byers